EvoNext Holdings SA (ELVAF)
OTCMKTS · Delayed Price · Currency is USD
0.9000
0.00 (0.00%)
At close: Jun 3, 2025
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of $9.87 million as of August 20, 2025. Its market cap has increased by 40.01% in one year.
Market Cap
9.87M
Enterprise Value
1.47M
Revenue
n/a
Ranking
n/a
PE Ratio
8.57
Stock Price
$0.90
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 361.87M to 9.87M, a decrease of -97.27%. That is a compound annual growth rate of -20.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 9.79M | 36.84% |
| Dec 30, 2024 | 7.16M | 22.89% |
| Dec 29, 2023 | 5.82M | -94.09% |
| Dec 30, 2022 | 98.47M | -29.13% |
| Dec 30, 2021 | 138.93M | -21.94% |
| Dec 30, 2020 | 177.97M | 1.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |